Satellites have come a long way in the last couple years, and what you learned about them in school is likely far different ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

The technology is stellar, and it really does offer a ton of advantages over gas and diesel. But the infrastructure might be ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.

Toyota usually does everything possible to avoid prying eyes seeing what happens at its proving grounds, but occasionally it ...

The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

Kyverna Therapeutics looks all the more likely to win the first FDA approval for a CAR-T therapy in an autoimmune disease after a registrational trial showed “highly statistically significant” ...

Lab-grown hearts with immune cells develop atrial fibrillation after chronic inflammation, offering a new way to test ...